Mymetics Corp (MYMX)

[Work Harder]

Series of preclinical studies supports the Army’s pan-coronavirus vaccine development strategy

“The accelerating emergence of human coronaviruses throughout the past two decades and the rise of SARS-CoV-2 variants, including most recently Omicron, underscore the continued need for next-generation preemptive vaccines that confer broad protection against coronavirus diseases,” said Dr. Kayvon Modjarrad, Director of the Emerging Infectious Diseases Branch at WRAIR, co-inventor of the vaccine and the U.S. Army lead for SpFN. “Our strategy has been to develop a ‘pan-coronavirus’ vaccine technology that could potentially offer safe, effective and durable protection against multiple coronavirus strains and species.”

https://www.army.mil/article/252890/series_of_preclinical_studies_supports_the_armys_pan_coronavirus_vaccine_development_strategy

https://eidresearch.org/node/4

Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

Inventors:

Barney Graham, Rockville, MD (US);
Wing-Pui Kong, Germantown, MD (US);
Kayvon Modjarrad, Bethesda, MD (US);
Lingshu Wang, North Potomac, MD (US);
Wei Shi, Rockville, MD (US);
Michael Gordon Joyce, Washington, DC (US);
Masaru Kanekiyo, Chevy Chase, MD (US)
John Mascola, Rockville, MD (US)

anything combined with lipid membranes like virosomes

https://www.lens.org/lens/patent/188-765-157-754-859/fulltext?l=EN

Toward a virosomal respiratory syncytial virus vaccine with a built-in lipophilic adjuvant
Lederhofer, Julia

https://pure.rug.nl/ws/portalfiles/portal/67431371/Complete_thesis.pdf

Modjarrad 6 refs